Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 787,062	$ 540,166	$ 463,090
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Investment income	(170,032)	(72,664)	(51,265)
Depreciation and amortization	0	0	1,581
Equity-based compensation	0	0	6,566
Net realized and unrealized (gain) loss from consolidated funds’ investments	(216,310)	(108,484)	28,137
Accretion of original issue and market discount of consolidated funds’ investments, net	(79,624)	(29,359)	(22,628)
Income distributions from corporate investments in funds and companies	68,390	62,622	111,904
SPAC deconsolidation gain and other non-cash items	3,450	(134)	(52,503)
Cash flows due to changes in operating assets and liabilities:
Net cash used in operating activities	(538,639)	(730,722)	(1,894,219)
Cash flows from investing activities:
Purchases of U.S. Treasury and other securities	(250,000)	0	(17,446)
Proceeds from maturities and sales of U.S. Treasury and other securities	80,000	0	12,948
Corporate investments in funds and companies	(34,944)	(488,280)	(308,394)
Distributions and proceeds from corporate investments in funds and companies	203,820	121,638	84,632
Purchases of fixed assets	0	0	(466)
Net cash used in investing activities	(1,124)	(366,642)	(228,726)
Cash flows from financing activities:
Net cash provided by financing activities	779,961	1,261,908	1,994,683
Effect of exchange rate changes on cash
Effect of exchange rate changes on cash	(9,875)	856	(26,248)
Net increase (decrease) in cash and cash-equivalents	230,323	165,400	(154,510)
Supplemental cash flow disclosures:
Deconsolidation due to restructuring	(8,805)	0	(94,367)
Deconsolidation of funds	(108,346)	(4,851)	(734,112)
Cash and Cash Equivalents
Cash and cash-equivalents, beginning balance	336,679	176,130	1,159,119
Cash and cash-equivalents, ending balance	449,851	336,679	176,130
Cash paid for interest	89,382	48,223	202,740
Cash paid for income taxes	0	0	8,786
Supplemental disclosure of non-cash activities:
Net assets related to the deconsolidation of funds	746,823	4,957	329,570
Net assets related to the deconsolidation due to 2024 and 2022 Restructuring	1,787,104	0	467,975
Reconciliation of cash and cash-equivalents
Total cash and cash-equivalents	449,851	336,679	176,130
Oaktree
Cash flows due to changes in operating assets and liabilities:
Decrease in deferred tax assets	0	0	505
(Increase)/ Decrease in other assets	(7,930)	11,775	(12,277)
Decrease in net due from affiliates	234,317	2,511	92,544
Increase (decrease) in accrued compensation expense	(91,865)	14,588	(1,387)
Increase (decrease) in accounts payable, accrued expenses and other liabilities	(691)	(645)	1,295
Cash flows from financing activities:
Capital contributions	99,527	581,502	146,892
Capital distributions	(271)	0	0
Distributions to Class A unitholders	(313,532)	(97,293)	(190,591)
Distributions to OCGH unitholders	(82,212)	(53,058)	(111,319)
Distributions to preferred unitholders	(27,316)	(27,316)	(27,316)
Proceeds from issuance of debt obligations	0	0	214,094
Payment of debt issuance costs	0	(128)	(1,311)
Cash and Cash Equivalents
Cash and cash-equivalents, beginning balance	28,507	9,514
Cash and cash-equivalents, ending balance	22,303	28,507	9,514
Reconciliation of cash and cash-equivalents
Total cash and cash-equivalents	22,303	28,507	9,514
Consolidated Funds
Cash flows due to changes in operating assets and liabilities:
Increase (decrease) in accounts payable, accrued expenses and other liabilities	(83,434)	99,194	13,869
Increase in dividends and interest receivable	(9,641)	(11,812)	(37,462)
Increase in due from brokers	0	0	(22,086)
(Increase) decrease in receivables for securities sold	34,995	(115,460)	132,654
(Increase) decrease in other assets	28,716	1,597	(22,693)
Increase (decrease) in payables for securities purchased	149,125	(28,525)	(275,532)
Purchases of securities	(4,083,590)	(4,800,884)	(7,730,412)
Proceeds from maturities and sales of securities	2,898,423	3,704,792	5,481,881
Cash flows from financing activities:
Payment of debt issuance costs	(3,378)	0	(7,611)
Contributions from non-controlling interests	470,924	1,223,103	727,382
Distributions to non-controlling interests	(655,263)	(315,998)	(207,360)
Proceeds from debt obligations issued by CLOs	0	0	2,575,561
Repayment on debt obligations issued by CLOs	0	0	(1,042,672)
Borrowings on credit facilities	3,065,915	1,341,800	592,275
Repayments on credit facilities	(1,774,433)	(1,390,704)	(673,341)
Cash and Cash Equivalents
Cash and cash-equivalents, beginning balance	308,172	166,616
Cash and cash-equivalents, ending balance	427,548	308,172	166,616
Reconciliation of cash and cash-equivalents
Total cash and cash-equivalents	$ 427,548	$ 308,172	$ 166,616